alexa New European Pharmacovigilance Legislation; Current Status And Issues - The Generics Perspective
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

John Barber
Keynote: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.010
Abstract
In July 2012, the new European Pharmacovigilance legislation started to come into effect. Final implementation is not expected until 2016. There are now just over two years experience with the implementation of the new legislation, and it is certainly no bed of roses. The aim of this session will be to review the status of the implementation of the new legislation and to look at some of these issues and concerns regarding the implementation. This will be from the perspective of the generics sector.
Biography
John Barber is currently the QPPV for Dr. Reddy?s Laboratories, UK, a role he has been in since April 2010. Prior to that, he was Global Clinical Pharmacovigilance Manager for Glenmark Pharmaceuticals, during which he initiated the development of the company?s Pharmacovigilance quality management system for its clinical development programme. He was previously employed by Alliance Pharmaceuticals, a specialist UK pharmaceutical company, where he was latterly Director of Scientific Affairs. In this role, he was responsible for Pharmacovigilance, medical information and clinical development. He also has experience as an information analyst with ICI Pharmaceuticals, Roche and Glaxo Wellcome. He is currently the Immediate Past President of the UK Pharmaceutical Information and Pharmacovigilance Association (PIPA) and is a lead on Pharmacovigilance issues for the British Generics Manufacturers Association (BGMA). By education, he is a pharmacologist, attaining a BSc (Hons) from the University of Liverpool.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords